Vistagen Therapeutics (VTGN) Income towards Parent Company (2011 - 2026)
Vistagen Therapeutics (VTGN) reported Income towards Parent Company of -$13.03 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$15.1 million a year earlier.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Income towards Parent Company (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vistagen Therapeutics' Income towards Parent Company came in at -$67.62 million; for FY2026 (ended Mar 31, 2026), it was -$69.69 million.
- By fiscal year, Income towards Parent Company came in at -$51.42 million in FY2025, -$29.36 million in FY2024, -$59.25 million in FY2023 and -$47.76 million in FY2022.
- The fiscal Q1 2027 figure ranks as the highest quarterly Income towards Parent Company since fiscal Q2 2025.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$16.27 million (Q4 2026), -$18.9 million (Q3 2026) and -$19.42 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.03 Mn |
| Mar 31, 2026 | -16.27 Mn |
| Dec 31, 2025 | -18.90 Mn |
| Sep 30, 2025 | -19.42 Mn |
| Jun 30, 2025 | -15.10 Mn |
| Mar 31, 2025 | -13.64 Mn |
| Dec 31, 2024 | -14.09 Mn |
| Sep 30, 2024 | -12.96 Mn |
| Jun 30, 2024 | -10.73 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Dec 31, 2023 | -6.35 Mn |
| Sep 30, 2023 | -6.59 Mn |
| Jun 30, 2023 | -6.90 Mn |
| Mar 31, 2023 | -12.23 Mn |
| Dec 31, 2022 | -9.76 Mn |
| Sep 30, 2022 | -17.48 Mn |
| Jun 30, 2022 | -19.78 Mn |
| Mar 31, 2022 | -16.69 Mn |
| Dec 31, 2021 | -10.53 Mn |
| Sep 30, 2021 | -12.80 Mn |
API Access
Vistagen Therapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();